[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] ZENG H, CHEN W, ZHENG R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries [J]. Lancet Glob Health, 2018, 6(5): e555-e567. [3] CAI Z, LIU Q. Understanding the Global Cancer Statistics 2018: implications for cancer control [J]. Sci China Life Sci, 2021, 64(6): 1017-1020. [4] PORTUONDO J I, TRAN CAO H S, DA COSTA W L, et al. Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer [J]. J Surg Oncol, 2021, 123(8): 1724-1735. [5] LAMERZ R. Role of tumour markers, cytogenetics [J]. Ann Oncol, 1999, 10 (Suppl 4):145-149. [6] CABILI M N, TRAPNELL C, GOFF L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses [J]. Genes Dev, 2011, 25(18): 1915-1927. [7] DERRIEN T, JOHNSON R, BUSSOTTI G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression [J]. Genome Res, 2012, 22(9): 1775-1789. [8] LI X, WU Z, FU X, et al. lncRNAs: insights into their function and mechanics in underlying disorders [J]. Mutat Res Rev Mutat Res, 2014, 762:1-21. [9] HUARTE M. The emerging role of lncRNAs in cancer [J]. Nat Med, 2015, 21(11): 1253-1261. [10] JIANG C, LI X, ZHAO H, et al. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis [J]. Mol Cancer, 2016, 15(1): 62. [11] MATTICK J S. RNA regulation: a new genetics? [J]. Nat Rev Genet, 2004, 5(4): 316-323. [12] WANG W W, ZHOU X L, SONG Y J, et al. Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer [J]. Onco Targets Ther, 2018, 11:2333-2344. [13] TANTAI J, HU D, YANG Y, et al. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer [J]. Int J Clin Exp Pathol, 2015, 8(7): 7887-7895. [14] LI N, FENG X B, TAN Q, et al. Identification of circulating long noncoding RNA Linc00152 as a novel biomarker for diagnosis and monitoring of non-small-cell lung cancer [J]. Dis Markers, 2017, 2017:7439698. |